Tectonic Therapeutic (TECX) Total Current Liabilities (2017 - 2026)
Tectonic Therapeutic's (TECX) quarterly Total Current Liabilities came in at $13.0 million in Q1 2026, up 34.06% on a QoQ basis from $9.7 million in Q4 2025.
Tectonic Therapeutic (TECX) Total Current Liabilities (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of Total Current Liabilities data on file, last reported at $13.0 million in Q1 2026.
- On a quarterly basis, Total Current Liabilities changed N/A year-over-year to $13.0 million in Q1 2026; TTM through Mar 2026 was $13.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $9.7 million, down 16.74% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $13.0 million, up from $9.7 million in the prior quarter.
- Over the last five years, Total Current Liabilities for TECX reached as high as $40.9 million in Q4 2023 and fell as low as $3.5 million in Q1 2024.
- Historically, Total Current Liabilities has averaged $14.7 million across 5 years, with a median of $12.9 million in 2022.
- Across the five-year window, Total Current Liabilities surged 211.77% in 2023 and sank 75.46% in 2024, its largest moves.
- Year by year, Total Current Liabilities stood at $13.1 million in 2022, then jumped by 211.77% to $40.9 million in 2023, then plunged by 71.61% to $11.6 million in 2024, then retreated by 16.74% to $9.7 million in 2025, then soared by 34.06% to $13.0 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $13.0 million in Q1 2026, $9.7 million in Q4 2025, and $9.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | Tectonic Therapeutic | 595.23 Mn | 595.23 Mn | - | 12.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.96 Mn |
| Dec 31, 2025 | 9.67 Mn |
| Sep 30, 2025 | 9.37 Mn |
| Jun 30, 2025 | 11.36 Mn |
| Dec 31, 2024 | 11.61 Mn |
| Sep 30, 2024 | 17.32 Mn |
| Jun 30, 2024 | 26.00 Mn |
| Mar 31, 2024 | 3.51 Mn |
| Dec 31, 2023 | 40.89 Mn |
| Sep 30, 2023 | 7.56 Mn |
| Jun 30, 2023 | 11.66 Mn |
| Mar 31, 2023 | 14.30 Mn |
| Dec 31, 2022 | 13.12 Mn |
| Sep 30, 2022 | 16.19 Mn |
| Jun 30, 2022 | 12.79 Mn |
| Mar 31, 2022 | 17.13 Mn |
| Dec 31, 2021 | 19.39 Mn |
| Sep 30, 2021 | 22.79 Mn |
| Jun 30, 2021 | 16.95 Mn |
| Mar 31, 2021 | 12.77 Mn |